Literature DB >> 18187045

Nuclear organization and chromatin dynamics--Sp1, Sp3 and histone deacetylases.

James R Davie1, Shihua He, Lin Li, Anoushe Sekhavat, Paula Espino, Bojan Drobic, Katherine L Dunn, Jian-Min Sun, Hou Yu Chen, Jenny Yu, Susan Pritchard, Xuemei Wang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18187045     DOI： 10.1016/j.advenzreg.2007.11.016

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  34 in total

1.  MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.

Authors:  Xinling Zhang; Leina Ma; Jieqiong Qi; Hui Shan; Wengong Yu; Yuchao Gu
Journal:  Mol Cell Biochem       Date:  2015-08-29       Impact factor: 3.396

2.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

3.  Human Telomerase Reverse Transcriptase (hTERT) Transcription Requires Sp1/Sp3 Binding to the Promoter and a Permissive Chromatin Environment.

Authors:  De Cheng; Yuanjun Zhao; Shuwen Wang; Wenwen Jia; Jiuhong Kang; Jiyue Zhu
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

4.  Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression.

Authors:  Tobias Bethge; Helen A Hachemi; Julia Manzetti; Rainer Gosert; Walter Schaffner; Hans H Hirsch
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation.

Authors:  Feifei Chen; Jian Song; Jiehui Di; Qing Zhang; Hui Tian; Junnian Zheng
Journal:  Tumour Biol       Date:  2012-08-14

6.  SP1 regulates the transcription of BMPR1A.

Authors:  Fadi S Dahdaleh; Jennifer C Carr; Daniel Calva; James R Howe; James R Howe
Journal:  J Surg Res       Date:  2011-07-23       Impact factor: 2.192

7.  Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression.

Authors:  X Wei Meng; Brian D Koh; Jin-San Zhang; Karen S Flatten; Paula A Schneider; Daniel D Billadeau; Allan D Hess; B Douglas Smith; Judith E Karp; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

8.  Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.

Authors:  Jun Wang; Min Kang; Yu-Tao Qin; Zhu-Xin Wei; Jing-Jian Xiao; Ren-Sheng Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.

Authors:  Mahadev Rao; Scott M Atay; Vivek Shukla; Young Hong; Trevor Upham; R Taylor Ripley; Julie A Hong; Mary Zhang; Emily Reardon; Patricia Fetsch; Markku Miettinen; Xinmin Li; Cody J Peer; Tristan Sissung; William D Figg; Assunta De Rienzo; Raphael Bueno; David S Schrump
Journal:  Clin Cancer Res       Date:  2015-10-12       Impact factor: 12.531

10.  Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.

Authors:  Xingruo Zeng; Zhou Xu; Jiayan Gu; Haishan Huang; Guangxun Gao; Xiaoru Zhang; Jingxia Li; Honglei Jin; Guosong Jiang; Hong Sun; Chuanshu Huang
Journal:  Mol Cancer Ther       Date:  2016-02-01       Impact factor: 6.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.